Peptide record

TPDB21224

Antibacterial Anticancer Antiviral Toxicity modified_plain modified
24 source-reported length (unverified)
Basic Information
TPDB21224
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia DRAVP 2.0
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide record curated from Peptipedia and DRAVP 2.0, without an available 3D structural model. Source-reported length: 24 (unverified).
Modified, details unspecified
Sequence
IEELLKKAEEQQKKNEEELKKLEX

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
24 source-reported length (unverified)
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
208.43±22.9 µM
Cytotoxic
50% Cytotoxicity | 208.43±22.9 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Structural and Functional Characterization of Membrane Fusion Inhibitors With Extremely Potent Activity Against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. | J Virol | 2018
Evidence 2 Activity

Activity

50% Cytotoxicity
Toxicity
49.95±2.97 µM
Cytotoxic
50% Cytotoxicity | 49.95±2.97 | µM | target cell: Human PBMC

Target

Human PBMC

Source & Reference

NA
DBAASP
Structural and Functional Characterization of Membrane Fusion Inhibitors With Extremely Potent Activity Against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. | J Virol | 2018
Evidence 3 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.30089693]TZM-bl cell:CC50=256.23 ±14.58 µM ##MT-4 cell:CC50=213.4±59.59 µM ##HEK293T cell:CC50=208.43± 22.9µM ##PBMC:CC50=49.95± 2.97 µM.

Source & Reference

NA
DRAMP
J Virol. 2018 Sep 26 92(20):e01088-18.